Executive Medical Director, Digital Strategy, Innovation & Channel Experience Head at Legend Biotech

United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, Pharmaceuticals, HealthcareIndustries

Requirements

Senior Medical Affairs leadership experience driving enterprise-wide digital transformation
Expertise in integrating advanced analytics, AI/ML, digital health technologies, and omnichannel engagement
Ability to define Medical Affairs digital vision and roadmap
Experience stewarding portfolio and product lifecycle for medical technology platforms
Strong governance, change management, and capability-building skills
Proficiency in establishing KPIs and closed-loop analytics for digital initiatives
Capability to align digital tools with business performance in a matrixed, global environment
Knowledge of adapting systems to evolving technologies and stakeholder needs
Scientific expertise to inform value-based innovation and strategic leadership

Responsibilities

Lead the global digital strategy and roadmap for Medical Affairs, integrating technology, analytics, and innovation to achieve strategic objectives
Drive digital transformation across Medical Affairs, focusing on evidence generation, content management, insights, and customer engagement
Architect and implement enterprise-level platforms and tools that enhance scalability, data integrity, and performance across medical systems
Evaluate and adopt emerging technologies, AI, and automation to modernize operations and strengthen cross-functional collaboration
Champion value-based innovation through the development of new products, platforms, and digital tactics informed by scientific expertise and strategic leadership
Develop and manage engagement strategies to ensure consistent, personalized, and compliant communication with healthcare professionals (HCPs), patients, and other stakeholders
Direct creation and dissemination of scientific content across portals, microsites, social media, and webinars, ensuring compliance with MLR review processes
Establish frameworks for content taxonomy, tagging, and asset management to support modular content reuse and global alignment
Enhance medical digital presence through campaigns that broaden reach and engagement of scientific communications and publications
Partner cross-functionally with Medical Affairs, Clinical/Development, Commercial, Informatics/IT, Data & Analytics, Experience/Customer Operations, Legal, Compliance, Regulatory, Value & Access, and Corporate/Scientific Communications teams

Skills

Digital Strategy

AI/ML

Digital Health Technologies

Omnichannel Engagement

Advanced Analytics

Medical Affairs

Stakeholder Engagement

Evidence Generation

Scientific Exchange

Digital Transformation

Legend Biotech

Develops and commercializes cell therapies

About Legend Biotech

Legend Biotech develops and commercializes cell therapies aimed at treating serious diseases, particularly cancers like hematological malignancies and solid tumors. Their approach is technology agnostic, allowing them to explore various methods to find effective treatments. The company operates in the personalized medicine sector, focusing on discovering, developing, and bringing new therapies to market. They generate revenue through licensing and selling their therapies, including CAR-T therapies, which involve modifying a patient's cells to combat cancer. Legend Biotech emphasizes transparency with investors, regularly updating them on financial results and business developments.

Franklin Township, New JerseyHeadquarters

2014Year Founded

$146.4MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

1,001-5,000Employees

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Paid Sick Leave

Paid Holidays

Remote Work Options

Risks

Increased competition from Amgen's Imdelltra may impact CAR-T therapy focus.

Collaboration with Multiply Labs may face technological challenges, delaying production timelines.

Financial strain from new R&D facility could affect operational focus if advancements lag.

Differentiation

Legend Biotech focuses on novel cell therapies for oncology, including CAR-T and NK cells.

The company is technology agnostic, exploring multiple platforms for effective cancer treatments.

Legend Biotech's CARVYKTI® is the first BCMA-targeted CAR-T therapy approved for second-line use.

Upsides

Recent FDA and European approvals for CARVYKTI® expand its market reach in multiple myeloma.

New R&D facility in Philadelphia boosts innovation in next-generation cell therapies.

Alan Bash's appointment could accelerate CARVYKTI®'s growth and market penetration.

Land your dream remote job 3x faster with AI

Try Jobo Free